FDA Approves Barr's Application To Sell Generic Version Of Oral Contraceptive Yasmin
Main Category: Women's Health / GynecologyAlso Included In: Sexual Health / STDs; Regulatory Affairs / Drug Approvals; Pharma Industry / Biotech Industry
Article Date: 14 May 2008 - 7:00 PDT
email to a friend 
printer friendly 
opinions
| Patient / Public: |  |
|
| Healthcare Prof: |  |
4 (1 votes) |
Barr Pharmaceuticals on Friday announced that FDA has approved its application to sell a generic version of Bayer Schering's oral contraceptive Yasmin in the U.S., Reuters reports (Reuters, 5/9).
In March, a federal court in New Jersey invalidated Bayer's patent on Yasmin, ruling in favor of a challenge filed by Barr (Daily Women's Health Policy Report, 3/5). Bayer has appealed the ruling to the U.S. District Court of Appeals for the Federal Circuit. Bayer also is suing Watson Pharmaceuticals and Sandoz over applications by the two companies to sell generic versions of Yasmin (AP/Forbes, 5/9).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2008 The Advisory Board Company. All rights reserved.
Visit our women's health / gynecology section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/107370.php>
APA
http://www.medicalnewstoday.com/releases/107370.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
